17-β-Estradiol-dependent regulation of somatostatin receptor subtype expression in the 7315b prolactin secreting rat pituitary tumor in vitro and in vivo

Endocrinology

Volumn 138, Issue 3, 1997, Pages 1180-1189

  Visser Wisselaar, H A ^a   Van Uffelen, C J C ^a   Van Koetsveld, P M ^a   Lichtenauer Kaligis, E G R ^a   Waaijers, A M ^a   Uitterlinden, P ^a   Mooy, D M ^a   Lamberts, S W J ^a   Hofland, L J ^a,b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTRADIOL; MESSENGER RNA; OCTREOTIDE; OCTREOTIDE[3 TYROSINE]; PROLACTIN; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FETAL CALF SERUM; GENE EXPRESSION; HORSE; HYPERPROLACTINEMIA; HYPOPHYSIS TUMOR; NONHUMAN; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; SERUM; TUMOR CELL CULTURE;

EID: 0031039556     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.3.5016     Document Type: Article

References (43)

1. Reichlin S 1983 Somatostatin. N Engl J Med 309:1495-1501
2. Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PPA, O'Carroll A-M, Patel YC, Schonbrunn A, Taylor JE, Reisine T 1995 Classification and nomenclature of Somatostatin receptors. Trends Pharmacol Sci 16:86-88
3. Lamberts SWJ, Krenning EP, Reubi J-C 1991 The role of Somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 12:450-482
4. 1]-octreotide: a case history. Ann NY Acad Sci 733:496-506
5. Lamberts SWJ, Reubi J-C, Uitterlinden P, Zuiderwijk J, van den Werff P, van Hal P 1986 Studies on the mechanism of action of the inhibitory effect of the Somatostatin analog SMS 201-995 on the growth of the prolactin/adrenocorticotropin-secreting pituitary tumor 7315a. Endocrinology 118:2188-2194
6. Lamberts SWJ, van Koetsveld PM, Verleun T 1987 Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells. Cancer Res 47:3667-3671
7. Hofland LJ, van Koetsveld PM, Wouters N, Waaijers M, Reubi J-C, Lamberts SWJ 1992 Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells. Endocrinology 131:571-577
8. Yen SSC, Siler TM, DeVane GW 1974 Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels. N Engl J Med 290:935-938
9. Drouin J, De Léan A, Rainville D, Lachance R, Labrie F 1976 Characteristics of the interaction between thyrotropin-releasing hormone and Somatostatin for thyrotropin and prolactin release. Endocrinology 98:514-521
10. Gooren LJG, Harmsen-Louman W, van Kessel H 1984 Somatostatin inhibits prolactin release from the lactotroph primed with oestrogen and cyproterone acetate in man. J Endocrinol 103:333-335
11. Kimura N, Hayafuji C, Konagaya H, Takahashi K 1986 17β-Estradiol induces Somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells. Endocrinology 119:1028-1036
12. Lamberts SWJ, Zuyderwijk J, Den Holder F, Van Koetsveld P, Hofland LJ 1989 Studies on the conditions of the effects of Somatostatin on adrenocorticotropin, prolactin and thyrotropin release by cultured rat pituitary cells. Neuroendocrinology 50:44-50
13. Pasqualini C, Bojda F, Kerdelhue B 1986 Direct effect of estradiol on the number of dopamine receptors in the anterior pituitary of ovariectomized rats. Endocrinology 119:2484-2489
14. Platia MP, Catt KJ, Aguilera G 1986 Effects of 17β-estradiol on angiotensin II receptors and prolactin release in cultured pituitary cells. Endocrinology 119:2768-2772
15. Hyde BA, Blaustein JD, Black DL 1989 Differential regulation of progestin receptor immunoreactivity in the rabbit oviduct. Endocrinology 125:1479-1483
16. Oosterom R, Verleun T, Lamberts SWJ 1983 Basal and dopamine-inhibited prolactin secretion by rat anterior pituitary cells: effects of culture conditions. Mol Cell Endocrinol 29:197-212
17. Fauser BCJM, Pache TD, Lamberts SWJ, Hop WCJ, de Jong FH, Dahl KD 1991 Serum bioactive and immunoreactive luteinizing hormone and follicle-stim-ulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. J Clin Endocrinol Metab 73:811-817
18. Reubi J-C 1985 New specific radioligand for one subpopulation of brain Somatostatin receptors. Life Sci 36:1829-1836
19. Wulfsen L, Meyerhof W, Fehr S, Richter D 1993 Expression patterns of rat somatostatin receptor genes in pre- and postnatal brain and pituitary. J Neurochem 61:1549-1552
20. Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, Imura H, Seino S, Seino Y 1994 Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analoque SMS 201-995 in treatment of human endocrine Tumors. J Clin Invest 93:1321-1325
21. Vidal C, Rauly I, Zeggari M, Delesque N, Esteve J-P, Saint-Laurent N, Vaysse N, Susini C 1994 Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells. Mol Pharmacol 45:97-104
22. Reubi J-C, Waser B, Horisberger U, Halter F, Soroka CJ, Kumar RR, Goldenring JR, Modlin IM 1992 Identification of somatostatin and gastrin receptors on enterochromaffin-like cells from Mastomys gastric tumors. Endocrinol 131:166-172
23. Scatchard G 1949 The attractions of proteins for small molecules and ions, Ann NY Acad Sci 51:660-672
24. Snedecor GW, Cochran WG 1980 Statistical Methods, ed 7. Iowa State University Press, Ames, pp 235-237
25. Lamberts SWJ, Verleun T 1987 Differences in the mechanism of the inhibitory actions of catecholestrogens, tamoxifen and high concentrations of estrogens on prolactin release by cultured rat pituitary tumor cells. Eur J Cancer Clin Oncol 23:1117-1123
26. Kimura N, Hayafuji C, Kimura N 1989 Characterization of 17-β-estradiol-dependent and -independent somatostatin receptor subtypes in rat anterior pituitary. J Biol Chem 264:7033-7040
27. Xu Y, Berelowitz M, Bruno JF 1995 Dexamethasone regulates somatostatin receptor subtype messenger ribonucleic acid expression in rat pituitary GH4C1 cells. Endocrinology 136:5070-5075
28. Brown MS, Goldstein JL 1986 A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47
29. Reubi JC, Horisberger U, Laissue J 1994 High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction? Int J Cancer 56:681-688
30. Leavitt WW, Cobb AD, Takeda A 1987 Progesteron-modulation of estrogen action: rapid down regulation of nuclear acceptor sites for the estrogen receptor. Adv Exp Med Biol 230:49-78
31. Bruno JF, Xu Y, Song J, Berelowitz M 1993 Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 133:2561-2567
32. Greenman Y, Melmed S 1994 Heterogeneous expression of two somatostatin receptor subtypes in pituitary tumors. J Clin Endocrinol Metab 78:398-403
33. Greenman Y, Melmed S 1994 Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab 79:724-729
34. Reubi JC, Schaer JC, Waser B, Mengod G 1994 Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 54:3455-3459
35. Panetta R, Patel YC 1995 Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors. Life Sci 56:333-342
36. Miller GM, Alexander JM, Bikkal HA, Katznelson L, Zervas NT, Klibanski A 1995 Somatostatin receptor subtype gene expression in pituitary adenomas. J Clin Endocrinol Metab 80:1386-1392
37. Lamberts SWJ, de Herder WW, Krenning EP, Reubi J-C 1994 A role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing's syndrome. J Clin Endocrinol Metab 78:17-19
38. Lamberts SWJ, Zweens M, Klijn JGM, van Vroonhoven CCJ, Stefanko SZ, Del Pozo E 1986 The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly. Clin Endocrinol 25:201-212
39. Reubi J-C, Heitz PU, Landolt AM 1987 Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses.J Clin Endocrinol Metab 65:65-73
40. Moyse E, Le Dafniet N, Epelbaum J, Pagesy P, Peillon F, Kordon C, Enjalbert A 1985 Somatostatin receptors in human growth hormone and prolactinsecreting pituitary adenomas. J Clin Endocrinol Metab 61:98-103
41. Lamberts SWJ, Hofland LJ, de Herder WW, Kwekkeboom DJ, Reubi J-C, Krenning EP 1993 Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy. Front Neuroendocrinol 14:27-55
42. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716-731
43. 3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide. Endocrinology 136:3698-3706